Building Support Systems for Pediatric HIV-1 in Ohio
GrantID: 60466
Grant Funding Amount Low: $850,000
Deadline: March 14, 2024
Grant Amount High: $1,250,000
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Business & Commerce grants, Children & Childcare grants, Faith Based grants, Higher Education grants, HIV/AIDS grants, Municipalities grants.
Grant Overview
Target Outcomes for Pediatric HIV Treatment in Ohio
The Grant to Expedite Drug Delivery for Pediatric HIV Treatment, funded by the Federal Government, aims to accelerate the development of long-acting, safe drug delivery devices for pediatric HIV-1 treatment. In Ohio, the successful implementation of this grant will focus on several key outcomes that address the unique needs of the state's population.
Advancing Preclinical Research for Pediatric HIV Treatment
One of the primary outcomes targeted by this grant in Ohio is the advancement of preclinical research for pediatric HIV treatment. Ohio is home to several renowned research institutions, including the Case Western Reserve University and Ohio State University, which have a strong track record of collaboration with industry partners. By supporting early-stage developers in performing preclinical activities for product optimization and translation, this grant will help bridge the gap between research and commercialization. The Ohio Department of Health's HIV/AIDS Program will likely play a crucial role in guiding the research towards the most pressing needs in the state.
Ohio's diverse geography, including its urban centers like Columbus and Cincinnati, and rural areas like Appalachian Ohio, presents a unique challenge in addressing pediatric HIV treatment. The state's rural areas often face difficulties in accessing healthcare services, making the development of long-acting drug delivery devices a critical need. By prioritizing the development of safe and effective treatments, this grant will help improve health outcomes for pediatric HIV patients across Ohio, particularly in underserved regions.
The grant's focus on collaboration with industry partners will also contribute to the growth of Ohio's bioscience sector. The state has been actively investing in its bioscience industry, with initiatives like the Ohio Third Frontier program, which provides funding and support for bioscience research and commercialization. By leveraging these resources, grant recipients in Ohio can accelerate the development of pediatric HIV treatments and create new opportunities for businesses and researchers in the state.
For small businesses in Ohio, this grant presents an opportunity to access funding and resources that can help drive innovation in pediatric HIV treatment. According to the Ohio Development Services Agency, small businesses are a vital part of the state's economy, and initiatives like this grant can help support their growth. By applying for this grant, small businesses in Ohio can tap into the state's strong research infrastructure and industry partnerships to develop new treatments and products.
In terms of grant money in Ohio, the Federal Government's investment in this initiative demonstrates its commitment to addressing the needs of pediatric HIV patients. With funding ranging from $850,000 to $1,250,000, this grant can support significant research and development activities in the state. As Ohio continues to navigate the challenges of pediatric HIV treatment, this grant will play a critical role in driving progress and improving health outcomes.
Measuring Success in Ohio
To measure the success of this grant in Ohio, the funder will likely track several key performance indicators, including the progress of preclinical research, the number of industry partnerships formed, and the eventual commercialization of new treatments. By monitoring these outcomes, the funder can assess the grant's impact on the state's pediatric HIV treatment landscape and make adjustments as needed.
Q: What are the primary outcomes targeted by this grant in Ohio? A: The primary outcomes targeted by this grant in Ohio include advancing preclinical research for pediatric HIV treatment and improving health outcomes for pediatric HIV patients across the state.
Q: How will the grant's focus on industry partnerships benefit Ohio's bioscience sector? A: The grant's focus on collaboration with industry partners will contribute to the growth of Ohio's bioscience sector by creating new opportunities for businesses and researchers in the state.
Q: What resources are available to small businesses in Ohio that are applying for this grant? A: Small businesses in Ohio can tap into the state's strong research infrastructure and industry partnerships, as well as initiatives like the Ohio Third Frontier program, to support their grant applications and research activities.
Eligible Regions
Interests
Eligible Requirements
Related Searches
Related Grants
Transportation Grants Program
Program Grants are to be awarded on a competitive basis to conduct demonstration projects focus...
TGP Grant ID:
16090
Teacher Scholarships
Supports talented science, technology, engineering, and mathematics undergraduate majors and profess...
TGP Grant ID:
876
Wong URL - Grant for Supporting Conservation for Marine and Endangered Species
TGP Grant ID:
68204
Transportation Grants Program
Deadline :
2022-11-18
Funding Amount:
$0
Program Grants are to be awarded on a competitive basis to conduct demonstration projects focused on advanced smart city or community technologie...
TGP Grant ID:
16090
Teacher Scholarships
Deadline :
2099-12-31
Funding Amount:
$0
Supports talented science, technology, engineering, and mathematics undergraduate majors and professionals to become effective K-12 STEM teachers...
TGP Grant ID:
876
Wong URL - Grant for Supporting Conservation for Marine and Endangered Species
Deadline :
2024-10-31
Funding Amount:
$0
TGP Grant ID:
68204